UBXN11 and neoplasm: Moreover, the combination of macitentan with olaparib interfered with the bidirectional signal exchange between HG-SOC cells and EC (Fig. 7F, H), as well as HG-SOC cells and activated fibroblasts (Fig. 7G, I), thus inhibiting tumor cell migration (Fig. 7H, I).